A detailed history of Clear Street Markets LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Clear Street Markets LLC holds 489 shares of TXG stock, worth $6,024. This represents 0.0% of its overall portfolio holdings.

Number of Shares
489
Holding current value
$6,024
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$13.18 - $21.31 $6,445 - $10,420
489 New
489 $7,000
Q3 2023

Nov 13, 2023

BUY
$40.86 - $62.98 $23,821 - $36,717
583 New
583 $24,000
Q2 2022

Aug 02, 2022

SELL
$36.95 - $82.41 $221 - $494
-6 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$55.7 - $145.79 $334 - $874
6 New
6 $0

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.17B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Clear Street Markets LLC Portfolio

Follow Clear Street Markets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Street Markets LLC with notifications on news.